ACE inhibitors in heart failure. What dose?
نویسندگان
چکیده
منابع مشابه
ACE inhibitors in heart failure. What dose?
Editorial Ace inhibitors in heart failure. What dose? The role of ACE (angiotensin converting enzyme) inhibitors in the treatment of heart failure is now well established. A large body of published work has demonstrated relief of symptoms, increased exercise performance, a reduction in hospital admissions and superiority to conventional vasodilators. Three large survival studies (CONSENSUS-1,' ...
متن کامل[Addition of an angiotensin II receptor blocker to maximal dose of ACE inhibitors in heart failure].
In heart failure, the benefits of adding angiotensin-receptor blockade to ACE inhibitors have been studied only with submaximal doses of ACE inhibitors. We included 20 patients (LVEF 24 7%, NYHA II-III), with no clinical or therapeutic variations in the previous three months, who were receiving maximal doses of ACE inhibitors. We added losartan 50 mg once a day. At six months, SBP decreased (11...
متن کاملACE inhibitors in heart failure: effect on mode of death.
The treatment of heart failure with ACE inhibitors, especially following acute myocardial infarction, is now well established. Several excellent studies have convincingly demonstrated increased survival and reduced morbidity necessitating fewer hospital admissions. In the Acute Infarction Ramipril Efficacy (AIRE) study 5 mg b.d. of the ACE inhibitor ramipril were given to patients with some cli...
متن کاملA survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure.
AIM To describe the pattern of angiotensin converting enzyme (ACE) inhibitor doses prescribed by general physicians for patients with chronic heart failure and to review the current evidence favouring the use of higher doses. DESIGN A retrospective survey of the medications of 125 patients with chronic heart failure (in both inpatient and outpatient settings) was carried out between December ...
متن کاملACE inhibitors in mild heart failure: first-line or second-line therapy?
Despite the successful therapeutic applications of angiotensin-converting enzyme (ACE) inhibitors to date, knowledge of how they work and guidelines for their use are still incomplete. On their role as monotherapy in congestive heart failure, we have scarce and conflicting data. Nor is there a clear answer to the question, when should an ACE inhibitor be started in a patient with heart failure?...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1995
ISSN: 0032-5473
DOI: 10.1136/pgmj.71.832.65